Peter Zdziarski: A Brighter Future for Glanzmann Thrombasthenia Through Gene Therapy
Peter Zdziarski, Vice President and Marketing Director at Glanzmann’s Research Foundation, shared a post on LinkedIn։
“It’s Rare Disease Day, and tomorrow is the official Glanzmann Thrombasthenia Awareness Day.
I was born with GT, and knowing that I may see gene therapy in my lifetime is incredible.
Through every challenge and every win, I wouldn’t change my journey.
The people I’ve met, the knowledge I’ve gained, and the places this path has taken me have shaped who I am, and I’m truly grateful.
Please consider donating to the Medical College of Wisconsin.
Every contribution moves us closer to a future where people with GT have more than just a couple of treatment options.
But a true solution.
A future with fewer antibodies from platelet transfusions, fewer dangerous bleeds, less bruising, and fewer long hospital stays.
The future is bright.
Donate toward gene therapy.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 19, 2026, 04:23Iris van Moort: Expert Insights on Pediatric Hemostasis Diagnostics at ISTH 2026
-
Jul 19, 2026, 04:09Er. Subodh Grewal: How Platelet Histograms Support Hematology Diagnosis
-
Jul 19, 2026, 03:53Serhii Pelishenko: Current Evidence on Kaolin and Chitosan Dressings
-
Jul 18, 2026, 23:52Chinua Onyebuchi: Applications Now Open for the European Stroke Master Programme
-
Jul 18, 2026, 22:43Exploring the Ultra-Late Window for Stroke Treatment – International Journal of Stroke
-
Jul 18, 2026, 21:38Swastik Sharma Deviprasad Bhat: A One-Minute Guide to Recognizing Stroke
-
Jul 18, 2026, 21:05Federica Fedele: From One-Size-Fits-All to Personalized Care
-
Jul 18, 2026, 21:04Sandra Rodríguez Coma: A Great Experience With the Werfen Team at ISTH 2026
-
Jul 18, 2026, 20:58Heghine Khachatryan: Cancer-Associated ATE – An Underrecognized Challenge in Modern Oncology